Currently usual doses of antifungal drugs are ineffective in most of the fungal infections. We prescribe usually double/triple drugs in higher doses for fungal infections to cure it.

In tuberculosis, there are MDR and XDR tuberculosis. When tuberculosis is resistant to at least two of the most powerful first-line anti-TB drugs isoniazid and rifampin, it is multidrug-resistant tuberculosis (MDR-TB). When tuberculosis is resistant to isoniazid and rifampin plus any fluoroquinolone and at least one of three injectable second-line drugs (i.e., amikacin, kanamycin, or capreomycin), it is extensively drug-resistant TB (XDR TB).

Like that of drug resistance tuberculosis, when should we label fungal infections as drug resistant infections?

More Harasit Kumar Paul's questions See All
Similar questions and discussions